Cheaper AI-run clinical trials: $1M phase 2a neurology trial announced
Afinetheorem · x · 2026-11-06
AI x bio announcements are heating up: after Citrini Research's 3-person team built a plausible scorpion antivenom binder in 3 days for $200k, Meri Beckwith announced a $1M AI-driven phase 2a clinical trial in neurology. Ruxandra Teslo argues that deploying AI on trials and better biomarkers — requiring in-human evidence — is where AI can truly impact biology.
More from Apps
- Fo Friends launches: AI agents now talk to each other to plan dinners and gifts — heyshrutimishra · 2026-11-06
- Executor v2 launches: Zapier/Retool-like automation fully drivable by code and AI agents — threepointone · 2026-11-06
- Dad uses ChatGPT to turn flight info into a picture-book trip map for his kid — yenkel · 2026-11-06
- From Greasemonkey to now: AI lets you mod any app just by describing the change — msfeldstein · 2026-11-06
- Investor accuses Anthropic of pumping his startup's engineers for secrets before launching rival Claude Personal Finance — Scobleizer · 2026-11-06
- Dev-built Optim Trends turns Shopify Analytics into visual feeds via ShopifyQL — sierracatalina · 2026-11-06